Home/Filings/4/0001391127-20-000030
4//SEC Filing

Fisher Jeffrey T 4

Accession 0001391127-20-000030

CIK 0001391127other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 5:00 PM ET

Size

35.4 KB

Accession

0001391127-20-000030

Insider Transaction Report

Form 4
Period: 2020-02-19
Transactions
  • Sale

    Common Stock

    2020-02-20$6.00/sh23,087$138,522322,231 total
  • Exercise/Conversion

    Common Stock

    2020-02-20$2.40/sh+34,025$81,660356,256 total
  • Sale

    Common Stock

    2020-02-20$6.00/sh34,025$204,150322,231 total
  • Exercise/Conversion

    Common Stock

    2020-02-20$2.39/sh+36,406$87,010358,637 total
  • Sale

    Common Stock

    2020-02-20$6.00/sh36,406$218,436322,231 total
  • Exercise/Conversion

    Common Stock

    2020-02-20$2.69/sh+33,559$90,274355,790 total
  • Sale

    Common Stock

    2020-02-20$6.00/sh33,559$201,354322,231 total
  • Exercise/Conversion

    Common Stock

    2020-02-20$4.10/sh+26,271$107,711348,502 total
  • Sale

    Common Stock

    2020-02-20$6.00/sh26,271$157,626322,231 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2020-02-19+20,0000 total
    Exercise: $4.00Exp: 2020-06-10Common Stock (20,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2020-02-20+23,0870 total
    Exercise: $4.77Exp: 2021-06-09Common Stock (23,087 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2020-02-20+34,0250 total
    Exercise: $2.40Exp: 2022-06-07Common Stock (34,025 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2020-02-20+36,4060 total
    Exercise: $2.39Exp: 2023-06-06Common Stock (36,406 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2020-02-20+33,5590 total
    Exercise: $2.69Exp: 2024-06-05Common Stock (33,559 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2020-02-20+26,2710 total
    Exercise: $4.10Exp: 2025-06-04Common Stock (26,271 underlying)
  • Exercise/Conversion

    Common Stock

    2020-02-19$4.00/sh+20,000$80,000342,231 total
  • Sale

    Common Stock

    2020-02-19$5.60/sh20,000$112,000322,231 total
  • Exercise/Conversion

    Common Stock

    2020-02-20$4.77/sh+23,087$110,125345,318 total
Footnotes (9)
  • [F1]Exercise of reporting person's stock options that would otherwise expire June 10, 2020 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
  • [F2]Price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions, and the range of sale prices for the transactions reported was $5.44 to $5.67. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price.
  • [F3]This includes 45,692 unvested restricted stock units.
  • [F4]Exercise of reporting person's stock options that would otherwise expire June 9, 2021 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
  • [F5]Exercise of reporting person's stock options that would otherwise expire June 7, 2022 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
  • [F6]Exercise of reporting person's stock options that would otherwise expire June 6, 2023 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
  • [F7]Exercise of reporting person's stock options that would otherwise expire June 5, 2024 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
  • [F8]Exercise of reporting person's stock options that would otherwise expire June 4, 2025 of which shares were sold to pay the exercise price, and broker fees and commissions, pursuant to a broker-assisted sell-to-cover order. Exercise was exercised pursuant to 10b5-1 plan adopted on November 20, 2019.
  • [F9]All such options have fully vested.

Issuer

Limelight Networks, Inc.

CIK 0001391127

Entity typeother

Related Parties

1
  • filerCIK 0001351411

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 5:00 PM ET
Size
35.4 KB